Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy

Gerard Ompad, Petra Maria Saura, Nicole Sonne Heckmann, Andrea Rossi, Elena Olmastroni, Manuela Casula, Maurizio Sessa

Open source

DOI
10.1186/s40360-026-01178-0
Published
2026-06-30
Container
BMC Pharmacology and Toxicology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40360-026-01178-0,
  title = {Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy},
  author = {Gerard Ompad and Petra Maria Saura and Nicole Sonne Heckmann and Andrea Rossi and Elena Olmastroni and Manuela Casula and Maurizio Sessa},
  year = {2026},
  journal = {BMC Pharmacology and Toxicology},
  doi = {10.1186/s40360-026-01178-0},
  url = {https://doi.org/10.1186/s40360-026-01178-0}
}

RIS

TY  - JOUR
TI  - Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy
AU  - Gerard Ompad
AU  - Petra Maria Saura
AU  - Nicole Sonne Heckmann
AU  - Andrea Rossi
AU  - Elena Olmastroni
AU  - Manuela Casula
AU  - Maurizio Sessa
PY  - 2026
JO  - BMC Pharmacology and Toxicology
DO  - 10.1186/s40360-026-01178-0
UR  - https://doi.org/10.1186/s40360-026-01178-0
ER  - 

APA

Ompad, G., Saura, P. M., Heckmann, N. S., Rossi, A., Olmastroni, E., Casula, M., & Sessa, M. (2026). Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-026-01178-0

Source records